Teprotumumab for Thyroid Eye Disease-related Strabismus.

Liane O DallalzadehGeorge A VillatoroLillian ChenMyung S SimMansoor MovagharShira L RobbinsJustin N KarlinMonica R KhitriFederico G VelezBobby S KornJoseph L DemerDaniel B RootmanDavid B GranetDon O Kikkawa

Published in: Ophthalmic plastic and reconstructive surgery (2024)

Teprotumumab produced a statistically significant reduction in vertical but not horizontal strabismus angles in primary position at distance. Extraocular motility in all 4 ductions also improved. A substantial minority of patients still required strabismus surgery following teprotumumab.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
minimally invasive
chronic kidney disease
peritoneal dialysis
coronary artery bypass
acute coronary syndrome
surgical site infection